2128 POSTER PTEN, EGFR, MAPK and Akt status by immunohistochemistry (IHC) in HER2-positive (HER2+) metastatic breast cancer (MBC) patients (pts) treated with trastuzumab (T) ± chemotherapy (CT): correlation with clinical outcome

✍ Scribed by S. Gori; V. De Angelis; A. Sidoni; M. Colozza; I. Ferri; D. Fenocchio; V. Ludovini; C. Basurto; P. Anastasi; L. Crinó

• Book ID: 118625732
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 61 KB
• Volume: 5
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(07)70890-x